DNA Plasmid Encoding a Modified Human Telomerase Reverse Transcriptase (hTERT), Invac-1 in Chronic Lymphocytic Leukemia
Clinical trial NCT03265717 · TERMINATED
Trial details
- NCT number
- NCT03265717
- Sponsor
- Invectys
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-25
- Primary completion
- 2020-06-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.